If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Humalog®
Humalog® U-100 (insulin lispro injection)
100 units/mLHumalog® U-200 (insulin lispro injection)
200 units/mLHumalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])
100 units/mLHumalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])
100 units/mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Administer the dose of IL-200 within 15 minutes before a meal or immediately after a meal by SC injection into the abdominal wall, thigh, upper arm, or buttocks.1
IL-200 is available only as a 3 mL Pen for SC use.1
Do NOT transfer IL-200 from the Pen to a syringe as the markings on the insulin syringe will not measure the dose correctly and can result in overdosage and severe hypoglycemia.1
Do NOT administer IL-200 using a CSII (eg, insulin pump).1
Do NOT administer IL-200 by IV infusion.1
Do NOT mix IL-200 with any other insulins.1
Enclosed Prescribing Information
HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly
1. Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
CSII = continuous subcutaneous insulin infusion
IL-200 = Humalog® (insulin lispro injection) 200 units/mL
IV = intravenous
Pen = KwikPen®
SC = subcutaneous
Date of Last Review: December 13, 2019
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST